New York Firm Raises $48 Million To Develop New Cancer Immunotherapies – Forbes

Forbes
… at Weill Cornell Medical by Laurie Glimcher, who was previously dean there and is now chief executive of the Dana-Farber Cancer Institute in Boston, and Juan Cubillos-Ruiz, an assistant professors of microbiology and immunonology. In Quentis

and more

…read more

Source:: New York City News By Google News

Leave a Comment